Forester Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Forester Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,430	Closed	-$158K	–	60
2016 Q3	$158K	Hold	3,430	–	–	0.15%	51
2016 Q2	$172K	Hold	3,430	–	–	0.16%	42
2016 Q1	$214K	Hold	3,430	–	–	0.2%	43
2015 Q4	$225K	Hold	3,430	–	–	0.2%	38
2015 Q3	$244K	Hold	3,430	–	–	0.23%	37
2015 Q2	$203K	Sell	3,430 -1,400	-29%	-$86.4K	0.16%	41
2015 Q1	$301K	Hold	4,830	–	–	0.24%	36
2014 Q4	$278K	Hold	4,830	–	–	0.21%	37
2014 Q3	$260K	Hold	4,830	–	–	0.2%	36
2014 Q2	$253K	Hold	4,830	–	–	0.2%	36
2014 Q1	$255K	Sell	4,830 -1,690	-26%	-$78.1K	0.2%	33
2013 Q4	$261K	Hold	6,520	–	–	0.21%	41
2013 Q3	$246K	Hold	6,520	–	–	0.2%	43
2013 Q2	$256K	Buy	+6,520	New	+$254K	0.21%	42

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Forester Capital Management's TEVA Position: Q4 2016 in Review

Forester Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 3,430 shares — an estimated $158K sold.

Forester Capital Management first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $301K in Q1 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Forester Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Forester Capital Management sold 3,430 Teva Pharmaceuticals shares in Q4 2016, an estimated $158K.
Forester Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Forester Capital Management's Teva Pharmaceuticals position peaked at $301K in Q1 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Forester Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.